2m 2m 2m 2m 2m 2m 2m
REMSleep Holdngs (RMSL)
OTC
$0.003+$0.0006 (+21.57%)
Price as of Jun 03, 2026- $3.7MMarket Cap
- -55.71%1-Year Change
- Medical DevicesIndustry
REMSleep Holdngs (RMSL)
$0.003+$0.0006 (+21.57%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 16,721 -85.73% | 117,185 -42.48% | 203,718 -36.48% | 320,719 N/A | |
Cost of Revenue | 12,707 -87.18% | 99,147 -89.68% | 960,457 +286.62% | 248,426 N/A | |
Gross Profit | 4,014 -77.75% | 18,038 +102.38% | -756,739 -1,146.77% | 72,293 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | -187,445 -36.42% | -294,819 -12.53% | -337,033 +160.64% | |
Depreciation and Amortization Expense | 35,453 -51.98% | 73,834 -27.75% | 102,198 +67.32% | 61,079 +6.11% | |
Total Operating Expenses | 2.8M +241.53% | 811,586 -20.03% | 1.0M -21.34% | 1.3M +203.08% | |
Operating Profit | -2.8M +248.78% | -793,548 -55.21% | -1.8M +45.47% | -1.2M +186.09% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -13,779 -94.20% | -237,390 -74.16% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -13,779 -94.20% | -237,390 -74.16% | |
Total Nonoperating Income and Expense | -252,528 -11.22% | -284,449 +4,490.85% | -6,196 -97.69% | -268,702 -92.10% | |
Income before Taxes | -3.0M +180.18% | -1.1M -39.36% | -1.8M +19.59% | -1.5M -61.14% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | 312,000 -61.15% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -1.1M -39.36% | -1.8M +19.59% | -1.5M -61.14% | |
Net Income from Continuing Operations Applicable to Common | -3.0M +180.18% | -1.1M -39.36% | -1.8M -12.13% | -2.0M -47.11% | |
Basic EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 N/A | 0.00 +100.00% | |
Diluted EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 N/A | 0.00 +100.00% | |
Basic Weighted Average Shares | 1.6B +6.18% | 1.5B +1.02% | 1.5B -0.02% | 1.5B +108.59% | |
Diluted Weighted Average Shares | 1.6B +6.18% | 1.5B +1.02% | 1.5B -0.02% | 1.5B +108.59% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 214,514 -53.70% | 463,343 -35.57% | 719,100 -60.96% | 1.8M -45.56% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 214,514 -53.70% | 463,343 -35.57% | 719,100 -60.96% | 1.8M -45.56% | |
Total Current Assets | 265,193 -46.07% | 491,734 -41.18% | 835,982 -71.27% | 2.9M -14.01% | |
Accumulated Depreciation | 109,728 -17.70% | 133,332 -12.77% | 152,854 +148.72% | 61,456 -53.18% | |
Property and Plant and Equipment and Net | 38,356 -48.03% | 73,809 -59.56% | 182,536 +32.29% | 137,980 +31.33% | |
Total Long-Term Assets | 10,000 0.00% | 10,000 0.00% | 10,000 0.00% | 10,000 0.00% | |
Total Assets | 339,756 -42.58% | 591,697 -50.95% | 1.2M -64.11% | 3.4M -3.94% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 52,199 +217.55% | 16,438 N/A | N/A N/A | 183,931 -55.94% | |
Total Current Liabilities | 299,641 +17.51% | 254,994 +9.94% | 231,938 -51.08% | 474,136 +143.53% | |
Total Long-Term Debt | 68,125 +3.22% | 66,000 -63.17% | 179,191 -33.99% | 271,467 N/A | |
Total Long-Term Liabilities | N/A N/A | 9,136 -79.08% | 43,676 -75.49% | 178,226 -38.69% | |
Total Liabilities | 307,694 +20.67% | 254,994 -7.48% | 275,614 -57.75% | 652,362 -25.87% | |
Retained Earnings | -18.3M +19.78% | -15.3M +7.60% | -14.2M +14.32% | -12.4M +19.47% | |
Total Stockholders Equity | 32,062 -90.48% | 336,703 -63.82% | 930,700 -65.64% | 2.7M +3.43% | |
Total Shares Outstanding | 1.7B +8.90% | 1.5B +4.24% | 1.5B 0.00% | 1.5B +18.44% | |
Cash Flow | |||||
Cash from Operating Activities | -502,829 -26.39% | -683,057 -13.68% | -791,329 -64.58% | -2.2M +538.31% | |
Capital Expenditures | N/A N/A | 124,700 -15.53% | 147,628 +20.75% | 122,262 +81.80% | |
Cash from Investing Activities | N/A N/A | -124,700 -15.53% | -147,628 +20.75% | -122,262 +81.80% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 254,000 -53.99% | 552,000 +400.11% | -183,931 -122.58% | 814,740 -77.90% | |
Financials Ratio | |||||
Gross Margin | 24.01% +55.95% | 15.39% +104.14% | -371.46% -1,747.96% | 22.54% N/A | |
Operating Margin | -16,552.67% +2,344.37% | -677.18% -22.13% | -869.65% +129.02% | -379.73% N/A | |
Return on Assets | N/A N/A | -119.91% +54.02% | -77.85% +79.62% | -43.34% -78.87% | |
Return on Equity | N/A N/A | -170.11% +74.11% | -97.70% +75.06% | -55.81% -87.25% | |
Revenue Growth | -85.73% +101.83% | -42.48% +16.44% | -36.48% N/A | N/A N/A | |
Current Ratio | 0.89 -54.11% | 1.93 -46.50% | 3.60 -41.27% | 6.14 -64.69% | |
Cash Ratio | 0.72 -60.60% | 1.82 -41.39% | 3.10 -20.19% | 3.88 -77.65% | |
Debt-to-Equity Ratio | 3.75 +1,433.05% | 0.24 N/A | N/A N/A | 0.17 N/A | |
Debt-to-Assets Ratio | 0.35 +154.20% | 0.14 N/A | N/A N/A | 0.14 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow